![Somatics Thymatron System IV Скачать руководство пользователя страница 77](http://html.mh-extra.com/html/somatics/thymatron-system-iv/thymatron-system-iv_user-manual_1317304077.webp)
Thymatron
®
System IV Instructions for Use
76
CAUTION
ADDENDUM III (INSTRUCTIONS TO PATIENT)
Safety Information
For patients with brain tumor, brain aneurysm, myocardial infarction, coronary insufficiency,
heart failure, or aortic aneurysm medical specialists in Neurology or Cardiology should be
consulted to determine additional precautions needed, if any.
When used as intended, this device provides short-term relief of symptoms. The long-term safety
and effectiveness of ECT treatment has not been demonstrated.
ECT device use may be associated with disorientation, confusion, and memory problems.
ECT treatment may be associated with disorientation, confusion and memory loss, including short-term
(anterograde) and long-term (autobiographical) memory loss following treatment. Based on the majority of
clinical evidence, these side effects tend to go away within a few days to a few months after the last treatment
with ECT. Although the incidence of permanent cognitive memory loss was not supported by the clinical
literature, some patients have reported a permanent loss of memories of personal life events (i.e.,
autobiographical memory).
Patients treated with ECT may experience manic symptoms (including euphoria and/or irritability, impulsivity,
racing thoughts, distractibility, grandiosity, increased activity, talkativeness, and decreased need for sleep) or a
worsening of the psychiatric symptoms they are being treated for. Depressed patients have committed suicide
even after ECT. Partial decrease in depression may increase risk of suicide.
The physical risks of ECT may include the following (in order of frequency of occurrence): Pain/somatic
discomfort (including headache, muscle soreness, and nausea); Skin burns; Physical trauma (including fractures,
contusions, injury from falls, dental and oral injury); Prolonged or delayed onset seizures; Pulmonary
complications (hypoxemia, hypoventilation, aspiration, upper-airway obstruction); Cardiovascular complications
(cardiac arrhythmias, heart attack, high or low blood pressure, and stroke); and death.
WARNING
WARNING
Содержание Thymatron System IV
Страница 57: ...Thymatron System IV Instructions for Use 56 ...
Страница 63: ...Thymatron System IV Instructions for Use 62 absorption and reflection from structures objects and people ...
Страница 79: ...Thymatron System IV Instructions for Use 78 ADDENDUM IV FLEXDIAL FLOW CHART ...
Страница 80: ...Thymatron System IV Instructions for Use 79 ADDENDUM V MOCA TEST ...